LMAT - LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system.
As of May 14, 2026: spot at $99.27, ATM IV 30.2%, net GEX -$40.4K.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Market Cap
- $2.24B
- P/E Ratio
- 35.87
- Beta
- 0.60
- 52-Week Range
- 78.35-118.01
- Dividend Yield
- $0.85
- CEO
- George W. LeMaitre
- Employees
- 651
- IPO Date
- Oct 19, 2006
- Exchange
- NASDAQ
What LMAT Looks Like to Options Traders Today
IV rank of 2.3% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); negative net gamma exposure (-$40.4K) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (0.015) is roughly flat across the wings.
What This Page Covers
The LMAT overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked LMAT overview questions
- What is LMAT?
- LMAT is the ticker symbol for LeMaitre Vascular, Inc., a listed security. LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. Listed on NASDAQ. LMAT is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the LMAT options snapshot look like today?
- As of May 14, 2026, the LMAT options snapshot shows spot at $99.27, ATM IV 30.2%, IV rank 2.3%, net GEX -$40.4K, expected move 8.66%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are LMAT's key statistics?
- LeMaitre Vascular, Inc. (LMAT) carries a market capitalization of $2.24B, trailing P/E ratio of 35.87, beta of 0.60 relative to the broader market, 52-week range of 78.35-118.01. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does LMAT belong to?
- LeMaitre Vascular, Inc. operates in the Healthcare sector, in the Medical - Instruments & Supplies industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare LMAT's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the LMAT data on this page?
- The options snapshot above is dated May 14, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).